ATE378015T1 - System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes - Google Patents

System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes

Info

Publication number
ATE378015T1
ATE378015T1 AT00945223T AT00945223T ATE378015T1 AT E378015 T1 ATE378015 T1 AT E378015T1 AT 00945223 T AT00945223 T AT 00945223T AT 00945223 T AT00945223 T AT 00945223T AT E378015 T1 ATE378015 T1 AT E378015T1
Authority
AT
Austria
Prior art keywords
anticoagulant
surrogate markers
patient
treating
prevent
Prior art date
Application number
AT00945223T
Other languages
English (en)
Inventor
John Mcmichael
Original Assignee
Dimensional Dosing Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dimensional Dosing Systems Inc filed Critical Dimensional Dosing Systems Inc
Application granted granted Critical
Publication of ATE378015T1 publication Critical patent/ATE378015T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electrotherapy Devices (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00945223T 1999-07-06 2000-07-06 System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes ATE378015T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/348,592 US6267116B1 (en) 1999-07-06 1999-07-06 Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug

Publications (1)

Publication Number Publication Date
ATE378015T1 true ATE378015T1 (de) 2007-11-15

Family

ID=23368686

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00945223T ATE378015T1 (de) 1999-07-06 2000-07-06 System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes

Country Status (15)

Country Link
US (2) US6267116B1 (de)
EP (1) EP1191894B1 (de)
JP (1) JP2003503165A (de)
KR (1) KR20020036790A (de)
CN (1) CN1359276A (de)
AT (1) ATE378015T1 (de)
AU (1) AU5919800A (de)
BR (1) BR0012241A (de)
CA (1) CA2362429C (de)
DE (1) DE60037116T2 (de)
IL (1) IL147201A0 (de)
MX (1) MXPA01013306A (de)
NO (2) NO20020043D0 (de)
TR (1) TR200103831T2 (de)
WO (1) WO2001002050A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
AU2001284868A1 (en) * 2000-08-24 2002-03-22 The Rxfiles Corporation Method and system for anticoagulant dose revision
US6883521B2 (en) * 2001-08-24 2005-04-26 Dimensional Dosing Systems, Inc. Method and apparatus for dosing single and multi-agent therapy
US6578582B2 (en) * 2001-08-24 2003-06-17 The Rxfiles Corporation Method and apparatus using IDS™ for multi-agent therapy
WO2003026727A1 (en) * 2001-09-28 2003-04-03 Lifevent Limited sETHOD AND APPARATUS FOR DELIVERY OF MEDICATION
US20050154537A1 (en) * 2003-12-12 2005-07-14 Kutzko John D. Methods, program products, and systems for single and multi-agent dosing and other related methods
DE602006019950D1 (de) * 2006-06-01 2011-03-17 Wila Bv Werkzeug mit automatischer Verriegelung
EP1862255B1 (de) * 2006-06-01 2011-03-16 Wila B.V. Auswechselbares Werkzeug/Manipulator Kombination
US20090216561A1 (en) * 2008-02-22 2009-08-27 Swedish Health Services Methods for management of anticoagulation therapy
US8112290B2 (en) * 2008-05-16 2012-02-07 Adolor Corporation Methods for delivering a drug to a hospital patient for short-term use while minimizing long-term use of the drug
US8688416B2 (en) * 2008-10-20 2014-04-01 Michael Fearon Methods and systems for improved pharmaceutical intervention in coagulation control
US9057731B2 (en) 2010-06-23 2015-06-16 University Of Louisville Research Foundation, Inc. Methods and kits for predicting a response to an erythropoietic agent
WO2013049624A1 (en) 2011-09-30 2013-04-04 University Of Louisville Research Foundation, Inc. System and method for personalized dosing of pharmacologic agents
EP2904388B1 (de) 2012-10-05 2023-06-07 Diane R. Mould System und verfahren zur bereitstellung patientenspezifischer dosierungen als funktion von mathematischen modellen
CA2988724C (en) 2015-04-09 2023-10-10 Diane R. Mould Systems and methods for patient-specific dosing
US20190043501A1 (en) * 2017-08-02 2019-02-07 Elements of Genius, Inc. Patient-centered assistive system for multi-therapy adherence intervention and care management
US20230107786A1 (en) * 2021-10-05 2023-04-06 Bradford RABIN Methods and systems for electronically adjusting a dosing pattern of a patient undergoing a medical regimen
KR20240033436A (ko) 2022-09-05 2024-03-12 박세경 휴대용 머신러닝 기반의 약물 부작용 탐지 시스템

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5365948A (en) * 1992-08-21 1994-11-22 J & W Mcmichael Software Inc. Method for use in treating a patient with FK 506 to prevent an adverse immune response
US5694950A (en) * 1992-08-21 1997-12-09 J & W Mcmichael Software, Inc. Method and system for use in treating a patient with immunosuppresants using whole blood level criteria to prevent an adverse immune response
US6581606B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method, apparatus and system for use in treating patient with a drug having an antineoplastic effect to optimize therapy and prevent an adverse drug response
US6581607B2 (en) * 1999-07-06 2003-06-24 The Rx Files Corporation Method and system for use in treating a patient with a biological substance to optimize therapy and prevent an adverse response
US6267116B1 (en) * 1999-07-06 2001-07-31 The Rxfiles Corporation Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
US6575169B2 (en) * 1999-07-06 2003-06-10 The Rxfiles Corporation Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug

Also Published As

Publication number Publication date
DE60037116D1 (de) 2007-12-27
CA2362429A1 (en) 2001-01-11
IL147201A0 (en) 2002-08-14
MXPA01013306A (es) 2002-07-02
US6267116B1 (en) 2001-07-31
AU5919800A (en) 2001-01-22
NO20020056L (no) 2002-01-07
WO2001002050A2 (en) 2001-01-11
KR20020036790A (ko) 2002-05-16
JP2003503165A (ja) 2003-01-28
EP1191894A2 (de) 2002-04-03
WO2001002050A3 (en) 2002-01-10
NO20020043D0 (no) 2002-01-04
EP1191894A4 (de) 2004-10-20
CN1359276A (zh) 2002-07-17
TR200103831T2 (tr) 2002-10-21
DE60037116T2 (de) 2008-09-11
CA2362429C (en) 2005-07-05
BR0012241A (pt) 2002-03-26
NO20020056D0 (no) 2002-01-07
US6942614B1 (en) 2005-09-13
EP1191894B1 (de) 2007-11-14

Similar Documents

Publication Publication Date Title
ATE378015T1 (de) System zur behandlung eines patienten mit einem medikament zur optimierung der therapie und zur verhinderung eines negativen nebeneffektes
ATE268477T1 (de) Verfahren, reagenz und messkartusche zur bestimmung der gerinnungszeit
ATE515229T1 (de) Vorrichtung zur erfassung eines markers zur überwachung der befolgung einer arzneimitteltherapie
NO996229D0 (no) Heparanase spesifikke molekylaere prober og deres anvendelse i forskning og medisin
FI904888A0 (fi) Foerfarande foer framstaellning av ett oestrogenhaltigt medikamentplaoster.
HUP9802264A2 (hu) A vér oxigénszintjének mérésére szolgáló rendszer
WO2003011215A3 (en) Method and system to determine revised dosage
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
WO2002082972A3 (en) Method and apparatus to optimize drug therapy
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
EP1162457A3 (de) Vielfach-Koagulationstestsystem und Verfahren zu seiner Anwendung
Slichter et al. Dysbaric osteonecrosis: a consequence of intravascular bubble formation, endothelial damage, and platelet thrombosis
Martin et al. Involvement of the lateral amygdala in the antiallodynic and reinforcing effects of heroin in rats after peripheral nerve injury
Shupack et al. Human skin reactions to ethylene oxide
DE69733169D1 (de) Verwendung von Alpha-1-Adrenorezeptor-Antagonisten zur Herstellung eines Medikaments für die Vorbeugung und die Behandlung von Krebs
DE3875826D1 (de) Methode, vorrichtung und testsatz zur messung der aktivitaet eines gewebeplasminogenaktivators.
ATE441437T1 (de) Verfahren zur identifizierung von respondern auf die behandlung mti insulinsensibilisatoren
Clark Knee synovectomy in hemophilia
Greenberg et al. Partial thromboplastin time as a predictor of blood loss in oral surgery patients receiving coumarin anticoagulants
Fisher Management of dermatitis due to surgical gloves
DE3650368T2 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
RO‘Brien An in vivo trial of an anti-adhesive drug
Palatucci Paradoxical halide levels in bromide intoxication
Woerlee et al. Perioperative Management of Platelet Disorders
Corcoran Essential Hypertension

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties